Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID‐19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID‐19
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume 75, Issue 2, Pages -
Publisher
Wiley
Online
2020-12-06
DOI
10.1111/ijcp.13896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection
- (2020) Moussa Saleh et al. Circulation-Arrhythmia and Electrophysiology
- QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
- (2020) Ehud Chorin et al. HEART RHYTHM
- Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association
- (2020) Dhanunjaya R. Lakkireddy et al. HEART RHYTHM
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Experience with Hydroxychloroquine and Azithromycin in the COVID‐19 Pandemic: Implications for QT Interval Monitoring
- (2020) Archana Ramireddy et al. Journal of the American Heart Association
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection
- (2020) Sok‐Sithikun Bun et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
- (2020) John R. Giudicessi et al. MAYO CLINIC PROCEEDINGS
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- The mechanisms of delayed onset type adverse reactions to oseltamivir
- (2016) Rokuro Hama Infectious Diseases
- Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes
- (2014) Hiroshi Ohara et al. Cardiovascular Toxicology
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
- (2013) James E. Tisdale et al.
- QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
- (2013) Katy E. Trinkley et al. CURRENT MEDICAL RESEARCH AND OPINION
- Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus
- (2013) Nadia D. Morgan et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Chloroquine Blocks a Mutant Kir2.1 Channel Responsible for Short QT Syndrome and Normalizes Repolarization Properties in silico
- (2009) Angelica Lopez-Izquierdo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search